Clinical trial
Evaluation of Long-Term Immunogenicity in Children and Adolescents Boosted With…
NCT00452621 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00452621 |
|---|---|
| Title | Evaluation of Long-Term Immunogenicity in Children and Adolescents Boosted With a New Pediatric TBE Vaccine After Five Years |
| Official title | A Phase IV, Uncontrolled, Open-Label, Multi-Center Study in Children and Adolescents: Evaluation of Long-Term Immunogenicity in Subjects Boosted With a New Pediatric TBE Vaccine (Free of Protein-Derived Stabilizer) in Study V48P4E1, Five Years After First Booster Immunization |
| Lead sponsor | Novartis, Industry |
| Collaborators | Novartis Vaccines Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Encephalitis, Tick-Borne |
| Intervention type | Procedure |
| Interventions | blood draw |
| Enrollment | 235 |
| Start date | Feb 1, 2007 |
| First posted | Mar 27, 2007 |
| Last update posted | Apr 23, 2008 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: